If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 192.00
Ask: 238.00
Change: 0.00 (0.00%)
Spread: 46.00 (23.958%)
Open: 215.00
High: 216.00
Low: 215.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

JZCP European Micro Cap Investments

21 Mar 2022 07:00

JZ Capital Partners Ltd - JZCP European Micro Cap Investments

JZ Capital Partners Ltd - JZCP European Micro Cap Investments

PR Newswire

London, March 20

JZ CAPITAL PARTNERS LIMITED(a closed-end collective investment scheme incorporated with limited liability under the laws of Guernsey with registered number 48761)LEI: 549300TZCK08Q16HHU44

JZCP European Micro Cap Investments

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014, WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

21 March 2022

JZ Capital Partners Limited ("JZCP" or the "Company") today announces that it has come to the Board's attention that allegations of fraudulent conduct potentially affecting JZCP's European micro-cap investments have been made. The allegations concern two individuals who were members of the management team that manages JZCP's investments in European micro-cap companies. A claim has been made in respect thereof in the New York State Supreme Court. The claimants are a fund in which JZCP has only an approximate 1% interest carried at approximately US$0.75m and also a fund in which JZCP has no interest. No allegations of fraudulent conduct were made against employees of the Company's investment adviser, Jordan/Zalaznick Advisers, Inc.

Whilst an investigation into the allegations is ongoing and therefore the information available to the Board at this time remains limited, the Company has no reason to believe that the alleged conduct will have a material adverse effect on the Company's investments in its European micro-cap portfolio. The Board will however make further announcements as and when appropriate once further information concerning the investigation and any potential impact on the Company becomes available.

The Company otherwise continues to remain confident of its ability to deliver on its investment policy including repayment of its debt obligations as they fall due subject as previously announced to the Company achieving sufficient realisations of its assets within the relevant timeframes.

Market Abuse Regulation

The information contained within this announcement is considered by the Company to constitute inside information as stipulated under MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

The person responsible for arranging the release of this announcement on behalf of the Company is David Macfarlane, Chairman of JZCP.

For further information:

Ed Berry / Kit Dunford FTI Consulting+44 (0)7703 330 199 / +44 (0)7717 417 038
David Zalaznick Jordan/Zalaznick Advisers, Inc.+1 (212) 485 9410
Sam Walden Northern Trust International Fund Administration Services (Guernsey) Limited+44 (0) 1481 745385

Important Notice

This announcement also includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements relate to matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. The Company's actual investment performance, results of operations, financial condition, liquidity, policies and the development of its strategies may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the investment performance, result of operations, financial condition, liquidity and policies of the Company and development of its strategies, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods. These forward-looking statements speak only as at the date of this announcement. Subject to their legal and regulatory obligations, each of the Company, Jordan/Zalaznick Advisers, Inc. and their respective affiliates expressly disclaims any obligations to update, review or revise any forward-looking statement contained herein whether to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based or as a result of new information, future developments or otherwise.

Date   Source Headline
16th Oct 20137:00 amRNSNet Asset Value(s)
16th Oct 20137:00 amRNSDividend Declaration
16th Oct 20137:00 amRNSHalf Yearly Report
27th Sep 201310:45 amRNSNotice of Interim Results
4th Sep 20138:45 amRNSExpansion of European Portfolio
21st Aug 20139:00 amRNSNet Asset Value(s)
16th Jul 20137:00 amRNSNet Asset Value(s)
25th Jun 20137:00 amRNSInterim Management Statement
24th Jun 20136:15 pmRNSResult of AGM
28th May 20136:09 pmRNSReplacement - Net Asset Value(s)
28th May 20134:30 pmRNSNet Asset Value(s)
22nd May 20134:00 pmRNSNotice of AGM and Annual Accounts to NSM
22nd May 20131:30 pmRNSDirector/PDMR Shareholding
21st May 20138:08 amRNSFinal Results
21st May 20137:01 amRNSDividend Declaration
14th May 20137:00 amRNSNet Asset Value(s)
29th Apr 20139:48 amRNSDirector Change/Update
10th Apr 20139:43 amRNSNotice of Results
25th Mar 201311:15 amRNSNet Asset Value(s)
19th Feb 20136:15 pmRNSHolding(s) in Company
5th Feb 201312:48 pmRNSDirector Declaration
17th Jan 201310:00 amRNSNet Asset Value(s)
19th Dec 20125:17 pmRNSNet Asset Value(s)
19th Dec 20127:00 amRNSInterim Management Statement
19th Nov 201211:30 amRNSNet Asset Value(s)
14th Nov 20121:45 pmRNSDirector/PDMR Shareholding
30th Oct 20127:00 amRNSHalf Yearly Report to NSM
19th Oct 201212:03 pmRNSNet Asset Value(s)
10th Oct 20124:00 pmRNSDirector/PDMR Shareholding
10th Oct 201210:00 amRNSDividend Declaration
10th Oct 20127:00 amRNSInterim Results
25th Sep 201210:15 amRNSNet Asset Value(s)
21st Sep 20128:56 amRNSNotice of Results
4th Sep 20123:43 pmRNSChange of Registered Office and Service Provider
24th Aug 20129:16 amRNSNet Asset Value(s)
31st Jul 20124:32 pmRNSTotal Voting Rights
24th Jul 20129:26 amRNSHolding(s) in Company
23rd Jul 20124:30 pmRNSHolding(s) in Company
23rd Jul 20124:05 pmRNSNet Asset Value(s)
20th Jul 201210:21 amRNSTotal Voting Rights
5th Jul 20129:15 amRNSNet Asset Value(s)
4th Jul 20127:00 amRNSInterim Management Statement
3rd Jul 20124:47 pmRNSAnnual General Meeting
3rd Jul 20123:25 pmRNSResults of Second General Meeting
3rd Jul 201211:43 amRNSResults of First General Meeting
7th Jun 20129:36 amRNSNet Asset Value(s)
1st Jun 20124:55 pmRNSHolding(s) in Company
22nd May 201212:31 pmRNSDirector/PDMR Shareholding
18th May 20127:02 amRNSProposed admission and other strategic initiatives
18th May 20127:01 amRNSDividend declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.